REPEATED EXPOSURE OF RATS TO THE CONVULSANT AGENT FLUROTHYL ENHANCES 5‐HYDROXYTRYPTAMINE‐ AND DOPAMINE‐MEDIATED BEHAVIOURAL RESPONSES
Open Access
- 1 March 1978
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 62 (3) , 325-331
- https://doi.org/10.1111/j.1476-5381.1978.tb08464.x
Abstract
1 Rats were convulsed once daily for 7 days by exposure to the inhalant convulsant agent, flurothyl (Indoklon, bis (2,2,2-trifluouroethyl)ether). Twenty four hours after the final convulsion the rats were injected with tranylcypromine (20 mg/kg) followed 30 min later by L-DOPA (50 mg/kg), a procedure which increases brain dopamine concentrations. The flurothyl-treated rats showed a greater locomotor activity response than rats that had not been convulsed. 2 This enhanced response appears to be due to increased postsynaptic dopamine receptor sensitivity since flurothyl-treated rats also showed enhanced locomotor responses to methamphetamine (2 mg/kg) and apomorphine (2 mg/kg). 3 Enhanced 5-hydroxytryptamine-induced activity responses following administration of tranylcypromine (20 mg/kg) and L-tryptophan (50 mg/kg) were also seen 24 h after the last of 10 daily flurothyl-induced convulsions. 4 The increased 5-hydroxytryptamine response also appears to be due to increased postsynaptic sensitivity since the flurothyl-treated rats showed increased hyperactivity following administration of tranylcypromine (20 mg/kg) and the suggested 5-hydroxytryptamine agonist, 5-methoxy N,N-dimethyltryptamine (2 mg/kg). 5 No change in the brain concentration of 5-hydroxytryptamine, 5-hydroxyindoleacetic acid, tryptophan, dopamine or noradrenaline was observed 24 h after the last of 10 daily flurothyl-induced convulsions, compared to untreated rats. The rate of 5-hydroxytryptamine accumulation after tranylcypromine/L-tryptophan treatment and of dopamine and noradrenaline accumulation after tranylcypromine/L-DOPA treatment was similar in both groups. 6 Repeated flurothyl convulsion has the same effects on these behavioural tests as repeated electro-convulsive shock. Since both treatments have been used successfully to treat depression, it is suggested that the mechanism of action of electroconvulsive therapy may be by increasing postsynaptic responses to the monoamine neurotransmitters.Keywords
This publication has 21 references indexed in Scilit:
- EVIDENCE CONCERNING THE INVOLVEMENT OF 5‐HYDROXYTRYPTAMINE IN THE LOCOMOTOR ACTIVITY PRODUCED BY AMPHETAMINE OR TRANYLCYPROMINE PLUS l‐DOPABritish Journal of Pharmacology, 1976
- Electroconvulsive shock and postsynaptic catecholamine effects: Increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECSJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1975
- The role of brain dopamine in the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in ratsNeuropharmacology, 1974
- Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by l‐tryptophan or 5‐methoxy‐N,N‐dimethyltryptamine in rats treated with a monoamine oxidase inhibitorBritish Journal of Pharmacology, 1971
- STUDIES IN VIVO ON THE RELATIONSHIP BETWEEN BRAIN TRYPTOPHAN, BRAIN 5‐HT SYNTHESIS AND HYPERACTIVITY IN RATS TREATED WITH A MONOAMINE OXIDASE INHIBITOR AND L‐TRYPTOPHANJournal of Neurochemistry, 1971
- Flurothyl (Indoklon)Anaesthesia, 1967
- A sensitive method for spectrophotofluorometric assay of catecholaminesInternational Journal of Neuropharmacology, 1964
- PHARMACOLOGIC STUDIES OF SOME NONHYDRAZINE MAO INHIBITORSAnnals of the New York Academy of Sciences, 1963
- EXPERIMENTAL STUDIES OF THE THERAPEUTIC ACTION OF ELECTROCONVULSIVE THERAPY IN ENDOGENOUS DEPRESSIONActa Psychiatrica Scandinavica, 1960
- New Pharmacoconvulsive AgentScience, 1957